Yurou Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yurou Yang

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Nanobiotechnology|January 19, 2025

Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.

NPJ Vaccines|November 1, 2022

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.

Nature Communications|June 7, 2020

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particlesDaning Wang, Xinlin Liu, Minxi Wei, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Nanobiotechnology|January 19, 2025

Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.

NPJ Vaccines|November 1, 2022

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.

Nature Communications|June 7, 2020

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particlesDaning Wang, Xinlin Liu, Minxi Wei, et al.

Pageof 2